EvidenceCare Launches The BetterCare Platform™ with AI Investment and CareInsights™

June 17, 2025 09:00 PM AEST | By EIN Presswire
 EvidenceCare Launches The BetterCare Platform™ with AI Investment and CareInsights™
Image source: EIN Presswire
NASHVILLE, TN, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- EvidenceCare, a leader in physician-centered clinical decision support, today announced the launch of The BetterCare Platform™—a unified framework of solutions designed to improve hospital performance. This launch creates a more connected, intelligent future of care that includes a company-wide investment in artificial intelligence to accelerate innovation across the platform, as well as the rebrand of the recently acquired Agathos product to CareInsights™.

While health systems face some of the most challenging times seen since the pandemic, The BetterCare Platform™ provides a best-in-class suite of solutions—AdmissionCare®, CareGauge®, CareInsights™, and CareIntelligence™—under one physician-centered platform designed to improve care quality and hospital financial performance.

In 2024 alone, EvidenceCare’s solutions generated more than $100 million in financial impact for its health system clients—driven by increased revenue capture and reduced cost of care.

“Health systems are facing unprecedented margin pressure, economic uncertainty, and clinical workforce shortages,” said Bo Bartholomew, CEO of EvidenceCare. “The BetterCare Platform reflects our commitment to empower clinicians with smart, trusted tools that not only improve outcomes but also protect physician time and strengthen hospital margins.”

Accelerating AI Development across the Platform

As part of this next chapter and its recent Series B funding, EvidenceCare has significantly expanded its AI development initiatives to power new innovations within the platform. This includes a strategic investment into the next generation of products and a deeper integration of AI capabilities into existing ones—setting the stage for product advancements that deliver smarter, faster clinical decisions.

“We’re not just investing in AI—we’re investing in the kind of AI that physicians trust and use,” said Dr. Brian Fengler, Co-founder and Chief Medical Officer. “Everything we build must improve their workflow and lead to better care decisions for their patients.”

New Name, Same Powerful Mission: Agathos is Now CareInsights™

Following the acquisition of Agathos, EvidenceCare is officially rebranding the solution as CareInsights™, aligning with the company’s broader product naming architecture and platform vision. The mobile-first tool delivers personalized, peer-comparison insights on clinical process metrics via text message, helping physicians reflect on clinical variation and improve care without the burden of administrative mandates and dashboards.

“Renaming Agathos to CareInsights is more than a branding decision—it’s a double-down on what we do and signal of our integration, growth, and missional focus,” said Andrew Trees, VP, Head of CareInsights and Agathos Co-founder. “We are thrilled to carry forward the success of Agathos while scaling our impact through The BetterCare Platform.”

---

About EvidenceCare
EvidenceCare is a physician-centered clinical decision support platform that empowers better care decisions throughout the patient’s hospital care journey with the vision that every clinical decision will deliver the right care at the right time.

Built to align clinical and financial goals, The BetterCare Platform™ optimizes clinical workflows, improves hospital margins, and enhances care quality—both inside and outside the EHR. Health systems across the country trust EvidenceCare to drive measurable outcomes without adding burden to clinicians.

Based in Nashville, Tennessee, EvidenceCare is a 3x honoree of the INC 5000 list of fastest growing companies, a 2x Fierce Healthcare Best Product winner, 2x honoree of The Tennessean’s Top Workplaces, and #3 nationally in Modern Healthcare’s Best Places to Work in Healthcare. Learn more at www.evidence.care

Spencer Holleman
EvidenceCare
[email protected]
Visit us on social media:
LinkedIn
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.